Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Eszopiclone
Drug ID BADD_D00837
Description Eszopiclone, marketed by Sepracor under the brand-name Lunesta, is a nonbenzodiazepine hypnotic drug used to treat insomnia. It is the active stereoisomer of zopiclone, belonging to the class of drugs known as _cyclopyrrolones_.[A179638,L6850] Cyclopyrrolone drugs demonstrate high efficacy and low toxicity[A179827], offering a safer alternative to other drugs used for insomnia. One major benefit of eszopiclone is that it is approved by the FDA for the long-term treatment of insomnia. This sets it apart from many other hypnotic sedatives, which are generally approved only for the relief of short-term (6-8 weeks) insomnia. Eszopiclone was initially approved by the FDA in 2004.[L6769]
Indications and Usage For the treatment of insomnia
Marketing Status Prescription; Discontinued
ATC Code N05CF04
DrugBank ID DB00402
KEGG ID D02624
MeSH ID D000069582
PubChem ID 969472
TTD Drug ID D06ZII
NDC Product Code 63402-191; 80425-0063; 0378-5270; 80425-0098; 65862-969; 43063-795; 63629-5319; 63187-970; 71335-0574; 68462-383; 71205-633; 68462-382; 68788-8077; 65862-968; 76420-024; 68180-322; 63278-1059; 80425-0115; 68180-324; 33342-300; 68788-6953; 33342-301; 61919-587; 70518-1310; 71205-581; 45865-830; 68180-323; 45865-829; 80425-0064; 71335-2002; 68788-7029; 55111-878; 50436-3384; 66022-0106; 71335-0089; 68788-7667; 63187-579; 50090-5084; 63187-843; 43353-185; 63187-817; 55111-619; 71335-0148; 80425-0066; 68462-384; 50090-3553; 0378-5272; 50090-3514; 60429-634; 50436-3383; 55700-581; 68071-2403; 61919-395; 61919-500; 66039-847; 0093-5539; 55700-610; 71335-0116; 61919-462; 60760-325; 55111-617; 71335-0005; 63187-665; 60429-633; 72789-067; 71335-0598; 68071-3376; 47335-587; 61919-119; 0378-5271; 66639-019; 45865-828; 71610-409; 55700-621; 47335-588; 72761-013; 70518-2979; 68788-7169; 63402-190; 47335-586; 43353-200; 72189-099; 65862-967; 50090-4202; 42043-320; 63402-193; 33342-299; 71335-1662; 61919-033; 80425-0062; 71205-384; 55289-014; 61919-514; 42043-321; 63285-831; 43353-097; 60760-511; 63285-832; 71335-1794; 76420-026; 71335-0512; 60760-526; 0093-5537; 11722-057; 71205-236; 76420-027; 80425-0168; 42043-322; 43353-101; 70518-3395; 0093-5538; 80425-0067; 50090-3989; 70518-0815; 80425-0065; 61919-991; 71205-513; 60429-632; 63285-830; 64330-044; 55111-629
Synonyms Eszopiclone | Lunesta | Estorra
Chemical Information
Molecular Formula C17H17ClN6O3
CAS Registry Number 138729-47-2
SMILES CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Disturbance in sexual arousal19.08.04.003--Not Available
Decreased appetite14.03.01.005; 08.01.09.0280.001009%
Ill-defined disorder08.01.03.049--Not Available
Abnormal sleep-related event17.15.02.007; 19.02.03.0090.001514%Not Available
Hyperlipidaemia14.08.03.001--
Respiratory tract infection22.07.07.001; 11.01.08.017--Not Available
Urethritis noninfective20.07.02.002--Not Available
Cystitis noninfective20.03.02.001--
Liver injury12.01.02.003; 09.01.07.022--Not Available
Drug-induced liver injury12.03.01.044; 09.01.07.0230.000263%Not Available
Alcohol interaction08.06.03.0030.001009%Not Available
Chronic gastritis11.07.01.016; 10.04.04.011; 07.08.02.0050.001009%Not Available
The 8th Page    First    Pre   8    Total 8 Pages